Cargando…
Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers
Antimicrobial drug concentrations in the gastrointestinal tract likely drive antimicrobial resistance in enteric bacteria. Our objective was to determine the concentration of ceftiofur and its metabolites in the gastrointestinal tract of steers treated with ceftiofur crystalline-free acid (CCFA) or...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777789/ https://www.ncbi.nlm.nih.gov/pubmed/31584976 http://dx.doi.org/10.1371/journal.pone.0223378 |
_version_ | 1783456668367978496 |
---|---|
author | Foster, Derek M. Jacob, Megan E. Farmer, Kyle A. Callahan, Benjamin J. Theriot, Casey M. Kathariou, Sophia Cernicchiaro, Natalia Prange, Timo Papich, Mark G. |
author_facet | Foster, Derek M. Jacob, Megan E. Farmer, Kyle A. Callahan, Benjamin J. Theriot, Casey M. Kathariou, Sophia Cernicchiaro, Natalia Prange, Timo Papich, Mark G. |
author_sort | Foster, Derek M. |
collection | PubMed |
description | Antimicrobial drug concentrations in the gastrointestinal tract likely drive antimicrobial resistance in enteric bacteria. Our objective was to determine the concentration of ceftiofur and its metabolites in the gastrointestinal tract of steers treated with ceftiofur crystalline-free acid (CCFA) or ceftiofur hydrochloride (CHCL), determine the effect of these drugs on the minimum inhibitory concentration (MIC) of fecal Escherichia coli, and evaluate shifts in the microbiome. Steers were administered either a single dose (6.6 mg/kg) of CCFA or 2.2 mg/kg of CHCL every 24 hours for 3 days. Ceftiofur and its metabolites were measured in the plasma, interstitium, ileum and colon. The concentration and MIC of fecal E. coli and the fecal microbiota composition were assessed after treatment. The maximum concentration of ceftiofur was higher in all sampled locations of steers treated with CHCL. Measurable drug persisted longer in the intestine of CCFA-treated steers. There was a significant decrease in E. coli concentration (P = 0.002) within 24 hours that persisted for 2 weeks after CCFA treatment. In CHCL-treated steers, the mean MIC of ceftiofur in E. coli peaked at 48 hours (mean MIC = 20.45 ug/ml, 95% CI = 10.29–40.63 ug/ml), and in CCFA-treated steers, mean MIC peaked at 96 hours (mean MIC = 10.68 ug/ml, 95% CI = 5.47–20.85 ug/ml). Shifts in the microbiome of steers in both groups were due to reductions in Firmicutes and increases in Bacteroidetes. CCFA leads to prolonged, low intestinal drug concentrations, and is associated with decreased E. coli concentration, an increased MIC of ceftiofur in E. coli at specific time points, and shifts in the fecal microbiota. CHCL led to higher intestinal drug concentrations over a shorter duration. Effects on E. coli concentration and the microbiome were smaller in this group, but the increase in the MIC of ceftiofur in fecal E. coli was similar. |
format | Online Article Text |
id | pubmed-6777789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-67777892019-10-13 Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers Foster, Derek M. Jacob, Megan E. Farmer, Kyle A. Callahan, Benjamin J. Theriot, Casey M. Kathariou, Sophia Cernicchiaro, Natalia Prange, Timo Papich, Mark G. PLoS One Research Article Antimicrobial drug concentrations in the gastrointestinal tract likely drive antimicrobial resistance in enteric bacteria. Our objective was to determine the concentration of ceftiofur and its metabolites in the gastrointestinal tract of steers treated with ceftiofur crystalline-free acid (CCFA) or ceftiofur hydrochloride (CHCL), determine the effect of these drugs on the minimum inhibitory concentration (MIC) of fecal Escherichia coli, and evaluate shifts in the microbiome. Steers were administered either a single dose (6.6 mg/kg) of CCFA or 2.2 mg/kg of CHCL every 24 hours for 3 days. Ceftiofur and its metabolites were measured in the plasma, interstitium, ileum and colon. The concentration and MIC of fecal E. coli and the fecal microbiota composition were assessed after treatment. The maximum concentration of ceftiofur was higher in all sampled locations of steers treated with CHCL. Measurable drug persisted longer in the intestine of CCFA-treated steers. There was a significant decrease in E. coli concentration (P = 0.002) within 24 hours that persisted for 2 weeks after CCFA treatment. In CHCL-treated steers, the mean MIC of ceftiofur in E. coli peaked at 48 hours (mean MIC = 20.45 ug/ml, 95% CI = 10.29–40.63 ug/ml), and in CCFA-treated steers, mean MIC peaked at 96 hours (mean MIC = 10.68 ug/ml, 95% CI = 5.47–20.85 ug/ml). Shifts in the microbiome of steers in both groups were due to reductions in Firmicutes and increases in Bacteroidetes. CCFA leads to prolonged, low intestinal drug concentrations, and is associated with decreased E. coli concentration, an increased MIC of ceftiofur in E. coli at specific time points, and shifts in the fecal microbiota. CHCL led to higher intestinal drug concentrations over a shorter duration. Effects on E. coli concentration and the microbiome were smaller in this group, but the increase in the MIC of ceftiofur in fecal E. coli was similar. Public Library of Science 2019-10-04 /pmc/articles/PMC6777789/ /pubmed/31584976 http://dx.doi.org/10.1371/journal.pone.0223378 Text en © 2019 Foster et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Foster, Derek M. Jacob, Megan E. Farmer, Kyle A. Callahan, Benjamin J. Theriot, Casey M. Kathariou, Sophia Cernicchiaro, Natalia Prange, Timo Papich, Mark G. Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers |
title | Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers |
title_full | Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers |
title_fullStr | Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers |
title_full_unstemmed | Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers |
title_short | Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers |
title_sort | ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal escherichia coli, and the microbiome of steers |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777789/ https://www.ncbi.nlm.nih.gov/pubmed/31584976 http://dx.doi.org/10.1371/journal.pone.0223378 |
work_keys_str_mv | AT fosterderekm ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT jacobmegane ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT farmerkylea ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT callahanbenjaminj ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT theriotcaseym ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT kathariousophia ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT cernicchiaronatalia ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT prangetimo ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers AT papichmarkg ceftiofurformulationdifferentiallyaffectstheintestinaldrugconcentrationresistanceoffecalescherichiacoliandthemicrobiomeofsteers |